J. O. Landman

Daily Oral Pamidronate in Women and Men With Osteoporosis: A 3‐Year Randomized Placebo‐Controlled Clinical Trial With a 2‐Year Open Extension

A. Zwinderman, P. Lips, E. McCloskey, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Uninterrupted oral bisphosphonate (pamidronate) therapy of patients with osteoporosis is not associated with chronic stimulation of parathyroid hormone secretion

S. Papapoulos, J. O. Landman, J. Landman, 1995, Osteoporosis International.

The use of bisphosphonates in the treatment of osteoporosis.

R. Valkema, E. Pauwels, C. Löwik, 1992, Bone.

Recovery of serum calcium concentrations following acute hypocalcemia in patients with osteoporosis on long-term oral therapy with the bisphosphonate pamidronate.

S. Papapoulos, N. Hamdy, M. Frölich, 1995, The Journal of clinical endocrinology and metabolism.

Bone mineral content of the forearm in healthy Dutch women.

J. Raymakers, R. Barentsen, J. O. Landman, 1988, Maturitas.

Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial.

B. Dijkmans, M. Westedt, F. Breedveld, 1996, Arthritis and rheumatism.

Skeletal metabolism in patients with osteoporosis after discontinuation of long-term treatment with oral pamidronate.

E. Pauwels, S. Papapoulos, N. Hamdy, 1995, The Journal of clinical endocrinology and metabolism.